ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CMO and CDMO biotechnology Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-1Z7112
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global CMO and CDMO biotechnology Market Insights Forecast to 2028
BUY CHAPTERS

Global CMO and CDMO biotechnology Market Research Report 2025

Code: QYRE-Auto-1Z7112
Report
July 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Patheon
Catalent
Lonza
Boehringer Ingelheim
AGC Biologics
Wuxi Biologics
AbbVie
Avid Bioservices
FUJIFILM Diosynth Biotechnologies
KBI Biopharma (JSR Corporation)
Cytovance Biologics
Xpress Biologic
Rentschler Biopharma
Samsung Biologics

CMO and CDMO biotechnology Market

The global market for CMO and CDMO biotechnology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for CMO and CDMO biotechnology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CMO and CDMO biotechnology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for CMO and CDMO biotechnology in Large Enterprise is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of CMO and CDMO biotechnology include Patheon, Catalent, Samsung Biologics, Lonza., Boehringer Ingelheim, Samsung BioLogics, AGC Biologics, WuXi Biologics, AbbVie, Avid Bioservices, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CMO and CDMO biotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CMO and CDMO biotechnology.
The CMO and CDMO biotechnology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CMO and CDMO biotechnology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CMO and CDMO biotechnology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of CMO and CDMO biotechnology Market Report

Report Metric Details
Report Name CMO and CDMO biotechnology Market
Segment by Type
  • Service
  • Product
  • Platform/ Expression System
Segment by Application
  • Large Enterprise
  • SME
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Patheon, Catalent, Samsung Biologics, Lonza., Boehringer Ingelheim, Samsung BioLogics, AGC Biologics, WuXi Biologics, AbbVie, Avid Bioservices, Fujifilm Diosynth Biotechnologies, KBI Biopharma (JSR Corporation), Cytovance Biologics, Xpress Biologic, Rentschler Biopharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of CMO and CDMO biotechnology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the CMO and CDMO biotechnology Market report?

Ans: The main players in the CMO and CDMO biotechnology Market are Patheon, Catalent, Samsung Biologics, Lonza., Boehringer Ingelheim, Samsung BioLogics, AGC Biologics, WuXi Biologics, AbbVie, Avid Bioservices, Fujifilm Diosynth Biotechnologies, KBI Biopharma (JSR Corporation), Cytovance Biologics, Xpress Biologic, Rentschler Biopharma

What are the Application segmentation covered in the CMO and CDMO biotechnology Market report?

Ans: The Applications covered in the CMO and CDMO biotechnology Market report are Large Enterprise, SME

What are the Type segmentation covered in the CMO and CDMO biotechnology Market report?

Ans: The Types covered in the CMO and CDMO biotechnology Market report are Service, Product, Platform/ Expression System

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CMO and CDMO biotechnology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Service
1.2.3 Product
1.2.4 Platform/ Expression System
1.3 Market by Application
1.3.1 Global CMO and CDMO biotechnology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Large Enterprise
1.3.3 SME
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CMO and CDMO biotechnology Market Perspective (2020-2031)
2.2 Global CMO and CDMO biotechnology Growth Trends by Region
2.2.1 Global CMO and CDMO biotechnology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CMO and CDMO biotechnology Historic Market Size by Region (2020-2025)
2.2.3 CMO and CDMO biotechnology Forecasted Market Size by Region (2026-2031)
2.3 CMO and CDMO biotechnology Market Dynamics
2.3.1 CMO and CDMO biotechnology Industry Trends
2.3.2 CMO and CDMO biotechnology Market Drivers
2.3.3 CMO and CDMO biotechnology Market Challenges
2.3.4 CMO and CDMO biotechnology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CMO and CDMO biotechnology Players by Revenue
3.1.1 Global Top CMO and CDMO biotechnology Players by Revenue (2020-2025)
3.1.2 Global CMO and CDMO biotechnology Revenue Market Share by Players (2020-2025)
3.2 Global CMO and CDMO biotechnology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CMO and CDMO biotechnology Revenue
3.4 Global CMO and CDMO biotechnology Market Concentration Ratio
3.4.1 Global CMO and CDMO biotechnology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CMO and CDMO biotechnology Revenue in 2024
3.5 Global Key Players of CMO and CDMO biotechnology Head office and Area Served
3.6 Global Key Players of CMO and CDMO biotechnology, Product and Application
3.7 Global Key Players of CMO and CDMO biotechnology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CMO and CDMO biotechnology Breakdown Data by Type
4.1 Global CMO and CDMO biotechnology Historic Market Size by Type (2020-2025)
4.2 Global CMO and CDMO biotechnology Forecasted Market Size by Type (2026-2031)
5 CMO and CDMO biotechnology Breakdown Data by Application
5.1 Global CMO and CDMO biotechnology Historic Market Size by Application (2020-2025)
5.2 Global CMO and CDMO biotechnology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CMO and CDMO biotechnology Market Size (2020-2031)
6.2 North America CMO and CDMO biotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CMO and CDMO biotechnology Market Size by Country (2020-2025)
6.4 North America CMO and CDMO biotechnology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CMO and CDMO biotechnology Market Size (2020-2031)
7.2 Europe CMO and CDMO biotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CMO and CDMO biotechnology Market Size by Country (2020-2025)
7.4 Europe CMO and CDMO biotechnology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CMO and CDMO biotechnology Market Size (2020-2031)
8.2 Asia-Pacific CMO and CDMO biotechnology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CMO and CDMO biotechnology Market Size by Region (2020-2025)
8.4 Asia-Pacific CMO and CDMO biotechnology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CMO and CDMO biotechnology Market Size (2020-2031)
9.2 Latin America CMO and CDMO biotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CMO and CDMO biotechnology Market Size by Country (2020-2025)
9.4 Latin America CMO and CDMO biotechnology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CMO and CDMO biotechnology Market Size (2020-2031)
10.2 Middle East & Africa CMO and CDMO biotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CMO and CDMO biotechnology Market Size by Country (2020-2025)
10.4 Middle East & Africa CMO and CDMO biotechnology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Patheon
11.1.1 Patheon Company Details
11.1.2 Patheon Business Overview
11.1.3 Patheon CMO and CDMO biotechnology Introduction
11.1.4 Patheon Revenue in CMO and CDMO biotechnology Business (2020-2025)
11.1.5 Patheon Recent Development
11.2 Catalent
11.2.1 Catalent Company Details
11.2.2 Catalent Business Overview
11.2.3 Catalent CMO and CDMO biotechnology Introduction
11.2.4 Catalent Revenue in CMO and CDMO biotechnology Business (2020-2025)
11.2.5 Catalent Recent Development
11.3 Samsung Biologics
11.3.1 Samsung Biologics Company Details
11.3.2 Samsung Biologics Business Overview
11.3.3 Samsung Biologics CMO and CDMO biotechnology Introduction
11.3.4 Samsung Biologics Revenue in CMO and CDMO biotechnology Business (2020-2025)
11.3.5 Samsung Biologics Recent Development
11.4 Lonza.
11.4.1 Lonza. Company Details
11.4.2 Lonza. Business Overview
11.4.3 Lonza. CMO and CDMO biotechnology Introduction
11.4.4 Lonza. Revenue in CMO and CDMO biotechnology Business (2020-2025)
11.4.5 Lonza. Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim CMO and CDMO biotechnology Introduction
11.5.4 Boehringer Ingelheim Revenue in CMO and CDMO biotechnology Business (2020-2025)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Samsung BioLogics
11.6.1 Samsung BioLogics Company Details
11.6.2 Samsung BioLogics Business Overview
11.6.3 Samsung BioLogics CMO and CDMO biotechnology Introduction
11.6.4 Samsung BioLogics Revenue in CMO and CDMO biotechnology Business (2020-2025)
11.6.5 Samsung BioLogics Recent Development
11.7 AGC Biologics
11.7.1 AGC Biologics Company Details
11.7.2 AGC Biologics Business Overview
11.7.3 AGC Biologics CMO and CDMO biotechnology Introduction
11.7.4 AGC Biologics Revenue in CMO and CDMO biotechnology Business (2020-2025)
11.7.5 AGC Biologics Recent Development
11.8 WuXi Biologics
11.8.1 WuXi Biologics Company Details
11.8.2 WuXi Biologics Business Overview
11.8.3 WuXi Biologics CMO and CDMO biotechnology Introduction
11.8.4 WuXi Biologics Revenue in CMO and CDMO biotechnology Business (2020-2025)
11.8.5 WuXi Biologics Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 AbbVie Business Overview
11.9.3 AbbVie CMO and CDMO biotechnology Introduction
11.9.4 AbbVie Revenue in CMO and CDMO biotechnology Business (2020-2025)
11.9.5 AbbVie Recent Development
11.10 Avid Bioservices
11.10.1 Avid Bioservices Company Details
11.10.2 Avid Bioservices Business Overview
11.10.3 Avid Bioservices CMO and CDMO biotechnology Introduction
11.10.4 Avid Bioservices Revenue in CMO and CDMO biotechnology Business (2020-2025)
11.10.5 Avid Bioservices Recent Development
11.11 Fujifilm Diosynth Biotechnologies
11.11.1 Fujifilm Diosynth Biotechnologies Company Details
11.11.2 Fujifilm Diosynth Biotechnologies Business Overview
11.11.3 Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Introduction
11.11.4 Fujifilm Diosynth Biotechnologies Revenue in CMO and CDMO biotechnology Business (2020-2025)
11.11.5 Fujifilm Diosynth Biotechnologies Recent Development
11.12 KBI Biopharma (JSR Corporation)
11.12.1 KBI Biopharma (JSR Corporation) Company Details
11.12.2 KBI Biopharma (JSR Corporation) Business Overview
11.12.3 KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Introduction
11.12.4 KBI Biopharma (JSR Corporation) Revenue in CMO and CDMO biotechnology Business (2020-2025)
11.12.5 KBI Biopharma (JSR Corporation) Recent Development
11.13 Cytovance Biologics
11.13.1 Cytovance Biologics Company Details
11.13.2 Cytovance Biologics Business Overview
11.13.3 Cytovance Biologics CMO and CDMO biotechnology Introduction
11.13.4 Cytovance Biologics Revenue in CMO and CDMO biotechnology Business (2020-2025)
11.13.5 Cytovance Biologics Recent Development
11.14 Xpress Biologic
11.14.1 Xpress Biologic Company Details
11.14.2 Xpress Biologic Business Overview
11.14.3 Xpress Biologic CMO and CDMO biotechnology Introduction
11.14.4 Xpress Biologic Revenue in CMO and CDMO biotechnology Business (2020-2025)
11.14.5 Xpress Biologic Recent Development
11.15 Rentschler Biopharma
11.15.1 Rentschler Biopharma Company Details
11.15.2 Rentschler Biopharma Business Overview
11.15.3 Rentschler Biopharma CMO and CDMO biotechnology Introduction
11.15.4 Rentschler Biopharma Revenue in CMO and CDMO biotechnology Business (2020-2025)
11.15.5 Rentschler Biopharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Patheon
Catalent
Lonza
Boehringer Ingelheim
AGC Biologics
Wuxi Biologics
AbbVie
Avid Bioservices
FUJIFILM Diosynth Biotechnologies
KBI Biopharma (JSR Corporation)
Cytovance Biologics
Xpress Biologic
Rentschler Biopharma
Samsung Biologics
List of Tables
 Table 1. Global CMO and CDMO biotechnology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Service
 Table 3. Key Players of Product
 Table 4. Key Players of Platform/ Expression System
 Table 5. Global CMO and CDMO biotechnology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global CMO and CDMO biotechnology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global CMO and CDMO biotechnology Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global CMO and CDMO biotechnology Market Share by Region (2020-2025)
 Table 9. Global CMO and CDMO biotechnology Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global CMO and CDMO biotechnology Market Share by Region (2026-2031)
 Table 11. CMO and CDMO biotechnology Market Trends
 Table 12. CMO and CDMO biotechnology Market Drivers
 Table 13. CMO and CDMO biotechnology Market Challenges
 Table 14. CMO and CDMO biotechnology Market Restraints
 Table 15. Global CMO and CDMO biotechnology Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global CMO and CDMO biotechnology Market Share by Players (2020-2025)
 Table 17. Global Top CMO and CDMO biotechnology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CMO and CDMO biotechnology as of 2024)
 Table 18. Ranking of Global Top CMO and CDMO biotechnology Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by CMO and CDMO biotechnology Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of CMO and CDMO biotechnology, Headquarters and Area Served
 Table 21. Global Key Players of CMO and CDMO biotechnology, Product and Application
 Table 22. Global Key Players of CMO and CDMO biotechnology, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global CMO and CDMO biotechnology Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global CMO and CDMO biotechnology Revenue Market Share by Type (2020-2025)
 Table 26. Global CMO and CDMO biotechnology Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global CMO and CDMO biotechnology Revenue Market Share by Type (2026-2031)
 Table 28. Global CMO and CDMO biotechnology Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global CMO and CDMO biotechnology Revenue Market Share by Application (2020-2025)
 Table 30. Global CMO and CDMO biotechnology Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global CMO and CDMO biotechnology Revenue Market Share by Application (2026-2031)
 Table 32. North America CMO and CDMO biotechnology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America CMO and CDMO biotechnology Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America CMO and CDMO biotechnology Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe CMO and CDMO biotechnology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe CMO and CDMO biotechnology Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe CMO and CDMO biotechnology Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific CMO and CDMO biotechnology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific CMO and CDMO biotechnology Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific CMO and CDMO biotechnology Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America CMO and CDMO biotechnology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America CMO and CDMO biotechnology Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America CMO and CDMO biotechnology Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa CMO and CDMO biotechnology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa CMO and CDMO biotechnology Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa CMO and CDMO biotechnology Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Patheon Company Details
 Table 48. Patheon Business Overview
 Table 49. Patheon CMO and CDMO biotechnology Product
 Table 50. Patheon Revenue in CMO and CDMO biotechnology Business (2020-2025) & (US$ Million)
 Table 51. Patheon Recent Development
 Table 52. Catalent Company Details
 Table 53. Catalent Business Overview
 Table 54. Catalent CMO and CDMO biotechnology Product
 Table 55. Catalent Revenue in CMO and CDMO biotechnology Business (2020-2025) & (US$ Million)
 Table 56. Catalent Recent Development
 Table 57. Samsung Biologics Company Details
 Table 58. Samsung Biologics Business Overview
 Table 59. Samsung Biologics CMO and CDMO biotechnology Product
 Table 60. Samsung Biologics Revenue in CMO and CDMO biotechnology Business (2020-2025) & (US$ Million)
 Table 61. Samsung Biologics Recent Development
 Table 62. Lonza. Company Details
 Table 63. Lonza. Business Overview
 Table 64. Lonza. CMO and CDMO biotechnology Product
 Table 65. Lonza. Revenue in CMO and CDMO biotechnology Business (2020-2025) & (US$ Million)
 Table 66. Lonza. Recent Development
 Table 67. Boehringer Ingelheim Company Details
 Table 68. Boehringer Ingelheim Business Overview
 Table 69. Boehringer Ingelheim CMO and CDMO biotechnology Product
 Table 70. Boehringer Ingelheim Revenue in CMO and CDMO biotechnology Business (2020-2025) & (US$ Million)
 Table 71. Boehringer Ingelheim Recent Development
 Table 72. Samsung BioLogics Company Details
 Table 73. Samsung BioLogics Business Overview
 Table 74. Samsung BioLogics CMO and CDMO biotechnology Product
 Table 75. Samsung BioLogics Revenue in CMO and CDMO biotechnology Business (2020-2025) & (US$ Million)
 Table 76. Samsung BioLogics Recent Development
 Table 77. AGC Biologics Company Details
 Table 78. AGC Biologics Business Overview
 Table 79. AGC Biologics CMO and CDMO biotechnology Product
 Table 80. AGC Biologics Revenue in CMO and CDMO biotechnology Business (2020-2025) & (US$ Million)
 Table 81. AGC Biologics Recent Development
 Table 82. WuXi Biologics Company Details
 Table 83. WuXi Biologics Business Overview
 Table 84. WuXi Biologics CMO and CDMO biotechnology Product
 Table 85. WuXi Biologics Revenue in CMO and CDMO biotechnology Business (2020-2025) & (US$ Million)
 Table 86. WuXi Biologics Recent Development
 Table 87. AbbVie Company Details
 Table 88. AbbVie Business Overview
 Table 89. AbbVie CMO and CDMO biotechnology Product
 Table 90. AbbVie Revenue in CMO and CDMO biotechnology Business (2020-2025) & (US$ Million)
 Table 91. AbbVie Recent Development
 Table 92. Avid Bioservices Company Details
 Table 93. Avid Bioservices Business Overview
 Table 94. Avid Bioservices CMO and CDMO biotechnology Product
 Table 95. Avid Bioservices Revenue in CMO and CDMO biotechnology Business (2020-2025) & (US$ Million)
 Table 96. Avid Bioservices Recent Development
 Table 97. Fujifilm Diosynth Biotechnologies Company Details
 Table 98. Fujifilm Diosynth Biotechnologies Business Overview
 Table 99. Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Product
 Table 100. Fujifilm Diosynth Biotechnologies Revenue in CMO and CDMO biotechnology Business (2020-2025) & (US$ Million)
 Table 101. Fujifilm Diosynth Biotechnologies Recent Development
 Table 102. KBI Biopharma (JSR Corporation) Company Details
 Table 103. KBI Biopharma (JSR Corporation) Business Overview
 Table 104. KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Product
 Table 105. KBI Biopharma (JSR Corporation) Revenue in CMO and CDMO biotechnology Business (2020-2025) & (US$ Million)
 Table 106. KBI Biopharma (JSR Corporation) Recent Development
 Table 107. Cytovance Biologics Company Details
 Table 108. Cytovance Biologics Business Overview
 Table 109. Cytovance Biologics CMO and CDMO biotechnology Product
 Table 110. Cytovance Biologics Revenue in CMO and CDMO biotechnology Business (2020-2025) & (US$ Million)
 Table 111. Cytovance Biologics Recent Development
 Table 112. Xpress Biologic Company Details
 Table 113. Xpress Biologic Business Overview
 Table 114. Xpress Biologic CMO and CDMO biotechnology Product
 Table 115. Xpress Biologic Revenue in CMO and CDMO biotechnology Business (2020-2025) & (US$ Million)
 Table 116. Xpress Biologic Recent Development
 Table 117. Rentschler Biopharma Company Details
 Table 118. Rentschler Biopharma Business Overview
 Table 119. Rentschler Biopharma CMO and CDMO biotechnology Product
 Table 120. Rentschler Biopharma Revenue in CMO and CDMO biotechnology Business (2020-2025) & (US$ Million)
 Table 121. Rentschler Biopharma Recent Development
 Table 122. Research Programs/Design for This Report
 Table 123. Key Data Information from Secondary Sources
 Table 124. Key Data Information from Primary Sources
 Table 125. Authors List of This Report


List of Figures
 Figure 1. CMO and CDMO biotechnology Picture
 Figure 2. Global CMO and CDMO biotechnology Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global CMO and CDMO biotechnology Market Share by Type: 2024 VS 2031
 Figure 4. Service Features
 Figure 5. Product Features
 Figure 6. Platform/ Expression System Features
 Figure 7. Global CMO and CDMO biotechnology Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global CMO and CDMO biotechnology Market Share by Application: 2024 VS 2031
 Figure 9. Large Enterprise Case Studies
 Figure 10. SME Case Studies
 Figure 11. CMO and CDMO biotechnology Report Years Considered
 Figure 12. Global CMO and CDMO biotechnology Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global CMO and CDMO biotechnology Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global CMO and CDMO biotechnology Market Share by Region: 2024 VS 2031
 Figure 15. Global CMO and CDMO biotechnology Market Share by Players in 2024
 Figure 16. Global Top CMO and CDMO biotechnology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CMO and CDMO biotechnology as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by CMO and CDMO biotechnology Revenue in 2024
 Figure 18. North America CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America CMO and CDMO biotechnology Market Share by Country (2020-2031)
 Figure 20. United States CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe CMO and CDMO biotechnology Market Share by Country (2020-2031)
 Figure 24. Germany CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific CMO and CDMO biotechnology Market Share by Region (2020-2031)
 Figure 32. China CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America CMO and CDMO biotechnology Market Share by Country (2020-2031)
 Figure 40. Mexico CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa CMO and CDMO biotechnology Market Share by Country (2020-2031)
 Figure 44. Turkey CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE CMO and CDMO biotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Patheon Revenue Growth Rate in CMO and CDMO biotechnology Business (2020-2025)
 Figure 48. Catalent Revenue Growth Rate in CMO and CDMO biotechnology Business (2020-2025)
 Figure 49. Samsung Biologics Revenue Growth Rate in CMO and CDMO biotechnology Business (2020-2025)
 Figure 50. Lonza. Revenue Growth Rate in CMO and CDMO biotechnology Business (2020-2025)
 Figure 51. Boehringer Ingelheim Revenue Growth Rate in CMO and CDMO biotechnology Business (2020-2025)
 Figure 52. Samsung BioLogics Revenue Growth Rate in CMO and CDMO biotechnology Business (2020-2025)
 Figure 53. AGC Biologics Revenue Growth Rate in CMO and CDMO biotechnology Business (2020-2025)
 Figure 54. WuXi Biologics Revenue Growth Rate in CMO and CDMO biotechnology Business (2020-2025)
 Figure 55. AbbVie Revenue Growth Rate in CMO and CDMO biotechnology Business (2020-2025)
 Figure 56. Avid Bioservices Revenue Growth Rate in CMO and CDMO biotechnology Business (2020-2025)
 Figure 57. Fujifilm Diosynth Biotechnologies Revenue Growth Rate in CMO and CDMO biotechnology Business (2020-2025)
 Figure 58. KBI Biopharma (JSR Corporation) Revenue Growth Rate in CMO and CDMO biotechnology Business (2020-2025)
 Figure 59. Cytovance Biologics Revenue Growth Rate in CMO and CDMO biotechnology Business (2020-2025)
 Figure 60. Xpress Biologic Revenue Growth Rate in CMO and CDMO biotechnology Business (2020-2025)
 Figure 61. Rentschler Biopharma Revenue Growth Rate in CMO and CDMO biotechnology Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Cell and Gene Therapy CDMO Market Research Report 2024
Global Gene Cell Therapy CDMO Market Research Report 2024
Global Cell Therapy CDMO Market Research Report 2025
Global Microbial CDMO Service Market Research Report 2024
Global Plasmid CDMO Services Market Research Report 2025
Plasmid DNA CDMO Market
Global Chemical API CDMO Market Research Report 2024
Global Cellular and Gene Therapy CDMO Market Research Report 2025
Global Antibody and Recombinant Protein CDMO Market Research Report 2025
Global Innovative Drug CDMO Market Research Report 2024
Global Small Molecule Innovator CDMO Market Research Report 2025
Global Pharmaceutical Intermediate CDMO Market Research Report 2024
Global Biologics Clinical Manufacturing CDMO Service Market Research Report 2024
Global Medical Device CDMO and CRO Market Research Report 2025
Global Exosome CDMO Market Research Report 2024
Medical Device CDMO Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mammalian CDMO Service Market Research Report 2024
Active Pharmaceutical Ingredients CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical CMO and CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Small Molecule CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions